NYSE: GPN
Global Payments
Financials · Services-Business Services, NEC
52-week range
$61.16$101.32
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$19.2B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.6B |
| FY2017, ended Dec 31, 2017 | $16.0B |
| FY2018, ended Dec 31, 2018 | $16.3B |
| FY2019, ended Dec 31, 2019 | $54.7B |
| FY2020, ended Dec 31, 2020 | $63.6B |
| FY2021, ended Dec 31, 2021 | $38.1B |
| FY2022, ended Dec 31, 2022 | $26.1B |
| FY2023, ended Dec 31, 2023 | $32.8B |
| FY2024, ended Dec 31, 2024 | $27.7B |
| FY2025, ended Dec 31, 2025 | $21.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $19.2B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$10.2B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.37B |
| FY2017, ended Dec 31, 2017 | $3.98B |
| FY2018, ended Dec 31, 2018 | $3.37B |
| FY2019, ended Dec 31, 2019 | $4.91B |
| FY2020, ended Dec 31, 2020 | $7.42B |
| FY2021, ended Dec 31, 2021 | $8.52B |
| FY2022, ended Dec 31, 2022 | $8.98B |
| FY2023, ended Dec 31, 2023 | $7.38B |
| FY2024, ended Dec 31, 2024 | $7.74B |
| FY2025, ended Dec 31, 2025 | $7.71B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $202M | — |
| FY2017, ended Dec 31, 2017 | $468M | $330M |
| FY2018, ended Dec 31, 2018 | $452M | $893M |
| FY2019, ended Dec 31, 2019 | $431M | $1.08B |
| FY2020, ended Dec 31, 2020 | $585M | $1.88B |
| FY2021, ended Dec 31, 2021 | $965M | $2.29B |
| FY2022, ended Dec 31, 2022 | $111M | $1.63B |
| FY2023, ended Dec 31, 2023 | $986M | $1.89B |
| FY2024, ended Dec 31, 2024 | $1.57B | $2.38B |
| FY2025, ended Dec 31, 2025 | $1.40B | $2.04B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$934M | $823M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$5.41B
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.16B |
| FY2017, ended Dec 31, 2017 | $1.34B |
| FY2018, ended Dec 31, 2018 | $1.21B |
| FY2019, ended Dec 31, 2019 | $1.68B |
| FY2020, ended Dec 31, 2020 | $1.95B |
| FY2021, ended Dec 31, 2021 | $1.98B |
| FY2022, ended Dec 31, 2022 | $2.00B |
| FY2023, ended Dec 31, 2023 | $2.09B |
| FY2024, ended Dec 31, 2024 | $2.36B |
| FY2025, ended Dec 31, 2025 | $8.34B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $5.41B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$22.5B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.44B |
| FY2017, ended Dec 31, 2017 | $4.66B |
| FY2018, ended Dec 31, 2018 | $5.13B |
| FY2019, ended Dec 31, 2019 | $9.13B |
| FY2020, ended Dec 31, 2020 | $9.29B |
| FY2021, ended Dec 31, 2021 | $11.4B |
| FY2022, ended Dec 31, 2022 | $13.5B |
| FY2023, ended Dec 31, 2023 | $16.4B |
| FY2024, ended Dec 31, 2024 | $16.3B |
| FY2025, ended Dec 31, 2025 | $21.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $22.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 73.8% since 2016.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.265M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 152M |
| FY2017, ended Dec 31, 2017 | 159M |
| FY2018, ended Dec 31, 2018 | 158M |
| FY2019, ended Dec 31, 2019 | 300M |
| FY2020, ended Dec 31, 2020 | 295M |
| FY2021, ended Dec 31, 2021 | 282M |
| FY2022, ended Dec 31, 2022 | 263M |
| FY2023, ended Dec 31, 2023 | 258M |
| FY2024, ended Dec 31, 2024 | 248M |
| FY2025, ended Dec 31, 2025 | 280M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 265M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Net: $1.47B more bought back than issued
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | — | — |
| FY2017, ended Dec 31, 2017 | $34.8M | $39.1M | $572M |
| FY2018, ended Dec 31, 2018 | $208M | $57.8M | — |
| FY2019, ended Dec 31, 2019 | $311M | $89.6M | $23.8B |
| FY2020, ended Dec 31, 2020 | $631M | $149M | — |
| FY2021, ended Dec 31, 2021 | $2.53B | $181M | — |
| FY2022, ended Dec 31, 2022 | $2.92B | $163M | — |
| FY2023, ended Dec 31, 2023 | $418M | $209M | — |
| FY2024, ended Dec 31, 2024 | $1.55B | $164M | — |
| FY2025, ended Dec 31, 2025 | $1.19B | $154M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.60B | $131M | — |
Revenue (TTM)
$10.2B
+32.2% YoY
Net income (TTM)
−$934M
−165% YoY
Cash
$5.41B
+107% YoY
Total debt
$22.5B
+39.8% YoY
Valuation
At current price- Market Cap
- $25.6B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.5×
- Price / Book
- 1.1×
- EV / EBITDA
- 11.5×
Growth
Trailing 12 months- Revenue (TTM)
- $10.2B
- Revenue Growth YoY
- 32.2%
- Revenue CAGR 3Y
- −5.0%
- Revenue CAGR 5Y
- 0.7%
- EPS Growth YoY
- −153%
- Net Income Growth YoY
- −165%
Profitability
Trailing 12 months- Gross Margin
- 63.9%
- Operating Margin
- 12.8%
- Net Margin
- −9.2%
- FCF Margin
- 8.1%
- Return on Equity
- −4.1%
Earnings
Trailing 12 months- Net Income
- −$934M
- EPS (diluted)
- −$3.03
- EBITDA
- $3.70B
- Operating Income
- $1.31B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $5.41B
- Total Debt
- $22.5B
- Net Debt
- $17.1B
- Total Assets
- $63.6B
- Total Liabilities
- $39.6B
- Shareholders' Equity
- $23.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.66B
- Capital Expenditure
- $835M
- Free Cash Flow
- $823M
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $1.00
- Beta (5Y)
- 0.80
Every ratio is calculated from the company’s reported figures.
Strength
Revenue grew 32.2% over the last year, to $10.2B.
Watch
Lost $934M over the last 12 months.
Note
Free cash flow of $823M, 8.1% of revenue.
Watch
Share count is up 9.1% in a year, diluting holders.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-K for the fiscal year ended Dec 31, 2025 · filed Feb 20, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2024 · 10-K72Good news
72Good news
10-K for the fiscal year ended Dec 31, 2024
Filed Feb 14, 2025 · Read the filing on EDGAR
- Revenue rose 4.7% to $10.1 billion and operating income rose 36% to $2.33 billion, helped by a $273.1 million gain on selling AdvancedMD.
- Net income rose to $1,570.4 million from $986.2 million, and operating cash flow rose to $3.53 billion.
- A new multi-year transformation targets over $600 million in annual operating income benefit by the first half of 2027, but brings costs and possible write-downs.
- Management is reviewing its business portfolio for more sales, and share buybacks rose to $1,552 million from $418.3 million.
Business momentum
Strong improvement
“Consolidated operating income for the year ended December 31, 2024 was $2,333.6 million, compared to $1,716.4 million for the prior year.”
Outlook
Positive
“We currently expect our transformation initiatives to generate more than $600 million of annual run-rate operating income benefit by the first half of 2027.”
Financial stress
Low
“We believe that our current and projected sources of liquidity will be sufficient to meet our projected liquidity requirements associated with our operations for the near and long term.”
Tone against the previous report
About the same
Red flags
- Minor
Large write-down
“During the year ended December 31, 2024, we recognized a charge of $55.8 million for technology assets that will no longer be utilized under a revised technology architecture development strategy.”
Positives
Both main business segments grew profit and margins
“Merchant Solutions segment operating income increased $267.7 million and operating margin increased 1.2% primarily due to the favorable effect of the increase in revenues”
Operating cash flow rose strongly
“Operating activities provided net cash of $3,532.7 million and $2,248.7 million for the years ended December 31, 2024 and 2023, respectively”
Large cost and profit benefit targeted from transformation
“We currently expect our transformation initiatives to generate more than $600 million of annual run-rate operating income benefit by the first half of 2027.”
Concerns
Profit jump owes much to one-off business sale results
“The combination of these items increased operating income by $409.9 million and had a favorable effect on operating margin of approximately 4.1% for the year ended December 31, 2024”
Issuer Solutions has limited cushion against a goodwill write-down
“except for our Issuer Solutions reporting unit, whose fair value exceeded its carrying amount by approximately 7% as of October 1, 2024”
Transformation costs and possible write-downs continue into 2027
“we have incurred and anticipate incurring incremental expenses related to the transformation and potential additional asset impairment charges through early 2027”
New risks since the previous report
Transformation program may fall short or disrupt the business
“Our strategic initiatives may not deliver the expected benefits within the anticipated timeframes.”
Business sales could bring write-downs and lower profits
“Moreover, we have incurred and in the future may incur asset impairment charges related to potential dispositions that reduce our profitability.”
Issuer customers may leave over technology modernization
“some Issuer Solutions customers may not be agreeable to our modernization efforts and may choose to end their contracts prematurely, or not renew their contracts as a result.”
New laws could limit interchange and processing fees
“interchange and/or other processing fees have recently become the subject of newly enacted and/or proposed new legislation”
AI rules could add cost and limit its use
“AI technology is subject to rapidly evolving domestic and international laws and regulations, which could impose significant costs and obligations on us.”
Biggest risks named
- Data breaches and cybersecurity failures
- Competition from larger rivals and new technology companies
- Substantial debt and possible credit rating downgrades
- Goodwill write-downs, especially in Issuer Solutions
- Transformation program and business sales failing to deliver or disrupting operations
Artificial intelligence in this business: Mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | +12 | |
| Outlook | +3 | |
| Tone against the previous report | 0 | |
| Financial stress | 0 | |
| Red flags | −1.5 | |
| New risks | −2 | |
| Score | 72 | |
Written by AI (Claude Opus 5.5) from the report’s text. 15 of 15 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-K | Feb 20, 2026 | Pro | |||
| 10-K | Feb 14, 2025 | 72 | Strong improvement | 1 minor | |
| 10-K | Feb 14, 2024 | 74 | Strong improvement | 1 medium | |
| 10-K | Feb 17, 2023 | 40 | Sharp deterioration | 1 medium1 minor | |
| 10-K | Feb 18, 2022 | 75 | Strong improvement | None | |
| 10-K | Feb 19, 2021 | 66 | Strong improvement | None | |
| 10-K | Feb 21, 2020 | 73 | Strong improvement | None | |
| 10-K | Feb 21, 2019 | 59 | Mixed | None | |
| 10-K | Feb 23, 2018 | 76 | Strong improvement | None | |
| 10-KT | Feb 28, 2017 | 59 | Mixed | None |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q2 FY2026 (period ended Jun 30, 2026), filed Aug 5, 2026. View filings on SEC EDGAR